Rallybio to Present at the 2024 Evercore ISI HealthCONx Conference
Rallybio (Nasdaq: RLYB), a clinical-stage biotech company focused on rare disease therapies, has announced its upcoming participation in the Evercore ISI HealthCONx Conference. Stephen Uden, M.D., CEO of Rallybio, will engage in a fireside chat on Wednesday, December 4, 2024 at 12:30 p.m. ET in Coral Gables, FL. The presentation will be available via live webcast through Rallybio's website, with a replay accessible for 30 days afterward.
Rallybio (Nasdaq: RLYB), una società biotecnologica in fase clinica focalizzata sulle terapie per malattie rare, ha annunciato la sua prossima partecipazione alla Evercore ISI HealthCONx Conference. Stephen Uden, M.D., CEO di Rallybio, parteciperà a un incontro informale il mercoledì 4 dicembre 2024 alle 12:30 p.m. ET a Coral Gables, FL. La presentazione sarà disponibile tramite webcast dal vivo sul sito web di Rallybio, con una registrazione accessibile per 30 giorni dopo.
Rallybio (Nasdaq: RLYB), una empresa biotecnológica en etapa clínica centrada en terapias para enfermedades raras, ha anunciado su próxima participación en la Evercore ISI HealthCONx Conference. Stephen Uden, M.D., CEO de Rallybio, participará en una charla informal el miércoles 4 de diciembre de 2024 a las 12:30 p.m. ET en Coral Gables, FL. La presentación estará disponible a través de una transmisión en vivo en el sitio web de Rallybio, con una repetición accesible durante 30 días después.
Rallybio (Nasdaq: RLYB)는 희귀 질병 치료에 중점을 둔 임상 단계의 생명 공학 회사로, Evercore ISI HealthCONx Conference에 곧 참가할 것이라고 발표했습니다. Stephen Uden, M.D.이 Rallybio의 CEO로, 2024년 12월 4일 수요일 오후 12시 30분 ET에 플로리다주 코랄 게이블스에서 진행되는 불가피한 대화에 참여할 것입니다. 발표는 Rallybio 웹사이트를 통해 실시간 웹캐스트로 제공되며, 이후 30일 동안 다시 볼 수 있습니다.
Rallybio (Nasdaq: RLYB), une entreprise biopharmaceutique en phase clinique axée sur les thérapies pour les maladies rares, a annoncé sa prochaine participation à la Evercore ISI HealthCONx Conference. Stephen Uden, M.D., PDG de Rallybio, participera à une discussion informelle le mercredi 4 décembre 2024 à 12h30 ET à Coral Gables, FL. La présentation sera disponible via un webinaire en direct sur le site de Rallybio, avec un replay accessible pendant 30 jours après.
Rallybio (Nasdaq: RLYB), ein biopharmazeutisches Unternehmen in klinischer Phase, das sich auf Therapien für seltene Krankheiten konzentriert, hat seine bevorstehende Teilnahme an der Evercore ISI HealthCONx Conference bekannt gegeben. Stephen Uden, M.D., CEO von Rallybio, wird am Mittwoch, den 4. Dezember 2024, um 12:30 Uhr ET in Coral Gables, FL, an einem informellen Gespräch teilnehmen. Die Präsentation wird über einen Live-Stream auf der Website von Rallybio verfügbar sein, und eine Wiederholung ist 30 Tage lang zugänglich.
- None.
- None.
A live webcast of the fireside chat will be accessible through the Events and Presentations section of Rallybio’s website at www.rallybio.com. An archived replay of the webcast will be available for 30 days following the presentation.
About Rallybio
Rallybio (NASDAQ: RLYB) is a clinical-stage biotechnology company with a mission to develop and commercialize life-transforming therapies for patients with severe and rare diseases. Rallybio has built a broad pipeline of promising product candidates aimed at addressing diseases with unmet medical need in areas of maternal fetal health, complement dysregulation, hematology, and metabolic disorders. The Company has two clinical stage programs: RLYB212, an anti-HPA-1a antibody for the prevention of fetal and neonatal alloimmune thrombocytopenia (FNAIT) and RLYB116, a C5 inhibitor with the potential to treat several diseases of complement dysregulation, as well as additional programs in preclinical development. Rallybio is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20241125485788/en/
Investor Contacts
Samantha Tracy
Rallybio Corporation
(475) 47-RALLY (Ext. 282)
investors@rallybio.com
Kevin Lui
Precision AQ
(212) 698-8691
Kevin.Lui@precisionaq.com
Media
Victoria Reynolds
Mission North
(760) 579-2134
rallybio@missionnorth.com
Source: Rallybio Corporation
FAQ
When is Rallybio (RLYB) presenting at the 2024 Evercore ISI HealthCONx Conference?
How can investors watch Rallybio's (RLYB) presentation at the 2024 HealthCONx Conference?
How long will Rallybio's (RLYB) 2024 HealthCONx Conference presentation be available for replay?
Who will represent Rallybio (RLYB) at the 2024 Evercore ISI HealthCONx Conference?
